Competitive Bidding Proposal Ignores Medical Reality

As a former FDA associate commissioner, I've spent my career at the intersection of clinical care, regulatory policy, and public health. And I understand the challenge federal agencies face when balancing fiscal responsibility with what's best for patients. Importantly, I recognize there are times when cost-saving proposals can have unintended negative consequences that ultimately compromise health outcomes, reduce innovation, and undermine trust in our institutions.